Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Share Price    (AUBD)

Here is the latest stock price and chart of AUROBINDO PHARMA. For more details, see the AUROBINDO PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Last Chance: Grab Your Free Spot for Rahul Shah's Lazy Millionaire Summit

REFRESH
Live BSE Quotes Jan 21, 2022 (Close)
Price (Rs)655.20 Open (Rs) 662.00 High (Rs) 676.00 Low (Rs) 650.05
% Change-0.97 Volume 109,816 Value (Rs) 72,480,974 52-Week H/L 1,063.75 / 620.55
Live NSE Quotes Jan 21, 2022 (Close)
Price (Rs)655.45 Open (Rs) 661.20 High (Rs) 676.60 Low (Rs) 650.10
% Change-0.87 Volume 2,118,832 Value (Rs) 1,398,658,952 52-Week H/L 1,063.90 / 620.50
Change
1 Day
-0.97%
1 Month
-5.56%
3 Months
-7.12%
1 Year
-27.41%
5 Years (CAGR)*
-1.11%
10 Years (CAGR)*
29.37%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 89.72 P/E Ratio (x) 7.30 Market Cap (Rs m) 383,906.97 P/BV (x) 1.75 Dividend Yield (%) 0.61
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AUROBINDO PHARMA Share Price Today:

AUROBINDO PHARMA last traded price was down 1.0% to Rs 655.2 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was down 0.9% to Rs 655.5. The total volume of shares traded was 2.2 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.4%. And the benchmark S&P BSE SENSEX was at 59,037.2 (down 0.7%).

Over the last 30 days, the AUROBINDO PHARMA share price is down 4.5%. And over the last one year, AUROBINDO PHARMA share price is down 29.5%.

The current market capitalisation of AUROBINDO PHARMA stands at Rs 383,906.97 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of December 2021, promoter pledging in AUROBINDO PHARMA stands at 22.97%. To know more, check out the latest shareholding pattern of AUROBINDO PHARMA.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - SYSCHEM (I). COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS